E

Entos, Inc

57 employees

Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Basic info

Industry

biotechnology research

Sectors

chemistry
batteries
molecular simulation
Artificial Intelligence
catalysis
pharmaceuticals
machine learning
Machine Learning
sustainability
artificial intelligence
quantum mechanics
drug discovery
materials
Therapeutics
biochemistry
Software
polymers
energy

Date founded

2019

Funding rounds raised

Total raised

$53M

from 6 investors over 6 rounds

E

Entos, Inc raised undisclosed on October 4, 2022

Investors: Hedonova

E

Entos, Inc raised $53M on July 14, 2021

Investors: FreeFlow App, Coatue Management, Nexus Venture Partners, Catalio Capital Management and OrbiMed Advisors

FAQ